Extremity Medical launched BioFuse, a next-gen viable cell bone graft for use in the foot, ankle, wrist and hand. The product complements Extremity Medical’s planned 2017 launches, such as the AXIS Charcot Fixation, KinematX Total Wrist Arthroplasty, MTP fusion and Jones fracture systems.
BioFuse comprises cells, biologic stimulants and a scaffold to support robust bone formation, with proprietary processing that allows rapid harvesting and reduced exposure to stressors that damage cells.
In vitro testing indicates that BioFuse provides higher levels of osteoinductive biologic stimulants and increased osteoconductivity vs. traditionally-processed live bone cell grafts.
Sources: Extremity Medical, LLC; ORTHOWORLD Inc.
Extremity Medical launched BioFuse, a next-gen viable cell bone graft for use in the foot, ankle, wrist and hand. The product complements Extremity Medical's planned 2017 launches, such as the AXIS Charcot Fixation, KinematX Total Wrist Arthroplasty, MTP fusion and Jones fracture systems.
BioFuse comprises cells, biologic stimulants and a...
Extremity Medical launched BioFuse, a next-gen viable cell bone graft for use in the foot, ankle, wrist and hand. The product complements Extremity Medical’s planned 2017 launches, such as the AXIS Charcot Fixation, KinematX Total Wrist Arthroplasty, MTP fusion and Jones fracture systems.
BioFuse comprises cells, biologic stimulants and a scaffold to support robust bone formation, with proprietary processing that allows rapid harvesting and reduced exposure to stressors that damage cells.
In vitro testing indicates that BioFuse provides higher levels of osteoinductive biologic stimulants and increased osteoconductivity vs. traditionally-processed live bone cell grafts.
Sources: Extremity Medical, LLC; ORTHOWORLD Inc.
You are out of free articles for this month
Subscribe as a Guest for $0 and unlock a total of 5 articles per month.
You are out of five articles for this month
Subscribe as an Executive Member for access to unlimited articles, THE
ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.
Our site uses cookies to allow easier access for Members and subscribers and to improve our site. You agree to our use of cookies by closing this message box or continuing to use our site.OkRead more
Copy to clipboard 
